Analytical Data
-
基因名
ACBD6
-
简介
ACBD6 protein selectively binds long-chain acyl-CoA, showing a significant preference for unsaturated C18:1-CoA. Unlike other variants such as unsaturated C20:4-CoA and saturated C16:0-CoA, ACBD6 does not bind to free fatty acids. ACBD6 Protein, Human (sf9, His) is the recombinant human-derived ACBD6 protein, expressed by Sf9 insect cells , with N-His labeled tag.
- Application
-
别名
Acyl-CoA-binding domain-containing protein 6; ACBD6
-
种属
Human
-
表达系统
Baculovirus
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BR61
-
表达区间
M1-A282
-
蛋白长度
Full Length
-
分子量
36 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The ACBD6 protein, a member of the acyl-CoA binding protein family, has garnered interest due to its potential roles in cellular metabolism and pathology. In recent years, research has indicated that ACBD6 is involved in lipid metabolism, suggesting a link to various metabolic disorders, including obesity and diabetes. Its ability to bind acyl-CoA suggests a regulatory function in fatty acid metabolism, influencing the biosynthesis and degradation of lipids. Additionally, ACBD6 has been implicated in cellular signaling pathways, including those affecting inflammation and cell proliferation. Given its involvement in multiple biological processes, understanding the mechanisms of ACBD6 action could offer insights into therapeutic strategies for metabolic diseases and associated conditions. Recent studies have also highlighted its expression patterns in various tissues under physiological and pathological states, pointing towards its potential as a biomarker for metabolic dysfunction. Thus, the exploration of ACBD6 as a recombinant protein has become essential for elucidating its structure-function relationships and provides a foundation for its application in metabolic disease research. As advancements in protein engineering and expression systems continue, the characterization of ACBD6 can facilitate the development of targeted interventions aimed at modulating its activity, opening new avenues for clinical applications in the management of metabolic disorders.
